FIS1 and Hyperglycemia: In parallel, MSCs treatment inhibited hyperglycemia-induced increase in Drp1 levels in rat aortas (Fig. 9b, a) but exerted no effect on the expression of OPA1, MFN2 and Fis1 (Fig. 9b, b–d).